Company Description (as filed with the SEC)
Telik, Inc. was incorporated in Delaware in 1988 and is a clinical-stage drug development company focused on discovering and developing small molecule drugs to treat cancer. We discover our product candidates using our proprietary drug discovery technology, Target-Related Affinity Profiling, or TRAP, which we believe enables the rapid and efficient discovery of small molecule product candidates. Our business strategy is to: • Establish FDA concurrence on the trial design of a Phase 3 registration study for TELINTRA. • Establish partnerships with a pharmaceutical or biotechnology company to assist in further development and commercialization of Telintra and other pipeline candidates. ... More ...